Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Tetra Pharm Technologies ApS
APS
Active
Advertising protection
CVR 40738223
Ørestads Boulevard 108, 2300
København S
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 6 years old
47 employees
https://www.tetrapharm.eu/
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Tetra Pharm Technologies ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JB
Jesper Breum Kanchanarat
Management
Management
2020
MS
Martin Stefan Rose
Management
Management
2019
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
CB
Claus Berner Nielsen
Board of Directors
Board of Directors
2026
SM
Søren Maarssø
Chairman
Chairman
2026
Former (4)
LF
Lars Frøvang Thomsen
Board of Directors
Board of Directors
2024 – 2026
SR
Søren Rose
Chairman
Chairman
2021 – 2025
PM
Per Mogens Bugge
Board of Directors
Board of Directors
2021 – 2024
NT
Nikolay Tretiyakov
Board of Directors
Board of Directors
2021 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nesroht Holding ApS
Company
25–33.32%
25–33.32%
2026
BrainFrame ApS
Company
20–24.99%
20–24.99%
2025
Breum Holding EST. 2016 ApS
Company
20–24.99%
20–24.99%
2025
RUMP INVEST ApS
Company
5–9.99%
5–9.99%
2026
Leafy Tunnel Fund 1, L.P.
Individual
5–9.99%
5–9.99%
2022
OLE GS HOLDING ApS
Company
5–9.99%
5–9.99%
2022
BWC Group Inc.
Individual
10–14.99%
10–14.99%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Tetra Pharm Technologies ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
